Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial

BACKGROUND: A randomised phase 2 trial of trimodality with or without induction chemotherapy (IC) in oesophageal cancer (EC) patients showed no advantage in overall survival (OS) or pathologic complete response rate. To identify subsets that might benefit from IC, a secondary analysis was done. METH...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Shimodaira, Yusuke, Slack, Rebecca S, Harada, Kazuto, Chen, Hsiang-Chun, Sagebiel, Tara, Bhutani, Manoop S, Lee, Jeffrey H, Weston, Brian, Elimova, Elena, Lin, Quan, Amlashi, Fatemeh G, Mizrak Kaya, Dilsa, Blum, Mariela A, Roth, Jack A, Swisher, Stephen G, Skinner, Heath D, Hofstetter, Wayne L, Rogers, Jane E, Mares, Jaennette, Thomas, Irene, Maru, Dipen M, Komaki, Ritsuko, Walsh, Garrett, Ajani, Jaffer A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2018
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808035/
https://ncbi.nlm.nih.gov/pubmed/29235564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.423
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados